Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 OBJECTIVES OF THE STUDY
1.3 MARKET DEFINITION
1.4 OVERVIEW OF GLOBAL HEATSTROKE TREATMENT MARKET
1.5 CURRENCY AND PRICING
1.6 LIMITATION
1.7 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL HEATSTROKE TREATMENT MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL HEATSTROKE TREATMENT MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE
5.2 PORTER’S 5 FORCES MODEL
6 EPIDEMIOLOGY
7 INDUSTRY INSIGHTS
8 PIPELINE ANALYSIS
8.1 PHASE III CANDIDATES
8.2 PHASE II CANDIDATES
8.3 PHASE I CANDIDATES
8.4 OTHERS (PRE-CLINICAL AND RESEARCH)
9 GLOBAL HEATSTROKE TREATMENT MARKET, BY TREATMENT
9.1 OVERVIEW
9.2 MEDICATION
9.2.1 BY DRUGS
9.2.1.1. MUSCLE RELAXANT DRUGS
9.2.1.1.1. BENZODIAZEPINES
9.2.1.1.2. DANTROLENE
9.2.1.1.3. OTHERS
9.2.1.2. ANTI-SEIZURES
9.2.1.2.1. CHLORPROMAZINE
9.2.1.2.2. PERPHENAZINE
9.2.1.2.3. VALPROIC ACID
9.2.1.2.4. OTHERS
9.2.1.3. OTHERS
9.2.2 BY ROUTE OF ADMINISTRATION
9.2.2.1. ORAL
9.2.2.2. PARENTERAL
9.2.2.3. OTHERS
9.3 COLD THERAPY
9.3.1 EXTERNAL (NON-INVASIVE) CONDUCTION THERAPY
9.3.1.1. ICE BLANKET
9.3.1.2. COLD WATER IMMERSION THERAPY
9.3.1.3. OTHERS
9.3.2 INTERNAL (INVASIVE) CONDUCTION THERAPY
9.3.2.1. GASTRIC, PERITONEAL OR BLADDER LAVAGE
9.3.2.2. COLD IV FLUIDS
9.3.2.3. OTHERS
9.4 SUPPORTIVE CARE
9.4.1 ELECTROLYTE
9.4.1.1. THERMOTABS
9.4.1.2. CERASPORT
9.4.1.3. TEMPTAB
9.4.1.4. ENFALYTE
9.4.1.5. NATURALYTE
9.4.1.6. REVITAL
9.4.1.7. OTHERS
9.4.2 OTHERS
10 GLOBAL HEATSTROKE TREATMENT MARKET, BY TYPE
10.1 OVERVIEW
10.2 EXERTIONAL
10.3 NON-EXERTIONAL
11 GLOBAL HEATSTROKE TREATMENT MARKET, BY MODE OF PURCHASE
11.1 OVERVIEW
11.2 PRESCRIPTION BASED
11.3 OVER THE COUNTER
12 GLOBAL HEATSTROKE TREATMENT MARKET, BY GENDER
12.1 OVERVIEW
12.2 MALE
12.3 FEMALE
13 GLOBAL HEATSTROKE TREATMENT MARKET, BY AGE GROUP
13.1 OVERVIEW
13.2 ADULT
13.3 PEDIATRIC
14 GLOBAL HEATSTROKE TREATMENT MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 CLINICS
14.4 HOMECARE
14.5 AMBULATORY SURGICAL CENTERS
14.6 HOME CARE SETTING
14.7 OTHERS
15 GLOBAL HEATSTROKE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 RETAIL SALES
15.4 HOSPITAL PHARMACIES
15.5 DRUGS STORES
15.6 OTHERS
15.6.1 ONLINE PHARMACIES
16 GLOBAL HEATSTROKE TREATMENT MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.2 COMPANY SHARE ANALYSIS: EUROPE
16.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS
16.8 REGULATORY CHANGES
16.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL HEATSTROKE TREATMENT MARKET, BY REGION
GLOBAL HEATSTROKE TREATMENT MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
17.2 EUROPE
17.2.1 GERMANY
17.2.2 FRANCE
17.2.3 U.K.
17.2.4 HUNGARY
17.2.5 LITHUANIA
17.2.6 AUSTRIA
17.2.7 IRELAND
17.2.8 NORWAY
17.2.9 POLAND
17.2.10 ITALY
17.2.11 SPAIN
17.2.12 RUSSIA
17.2.13 TURKEY
17.2.14 NETHERLANDS
17.2.15 SWITZERLAND
17.2.16 REST OF EUROPE
17.3 ASIA-PACIFIC
17.3.1 JAPAN
17.3.2 CHINA
17.3.3 SOUTH KOREA
17.3.4 INDIA
17.3.5 AUSTRALIA
17.3.6 SINGAPORE
17.3.7 THAILAND
17.3.8 MALAYSIA
17.3.9 INDONESIA
17.3.10 PHILIPPINES
17.3.11 VIETNAM
17.3.12 REST OF ASIA-PACIFIC
17.4 SOUTH AMERICA
17.4.1 BRAZIL
17.4.2 ARGENTINA
17.4.3 PERU
17.4.4 REST OF SOUTH AMERICA
17.5 MIDDLE EAST AND AFRICA
17.5.1 SOUTH AFRICA
17.5.2 SAUDI ARABIA
17.5.3 UAE
17.5.4 EGYPT
17.5.5 KUWAIT
17.5.6 ISRAEL
17.5.7 REST OF MIDDLE EAST AND AFRICA
17.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
18 GLOBAL HEATSTROKE TREATMENT MARKET, COMPANY PROFILE
18.1 (SWOT AND DBMR ANALYSIS OF TOP 5 COMPANIES WILL BE PROVIDED)
18.2 CRYOTHERMIC SYSTEMS INCORPORATED
18.2.1 COMPANY OVERVIEW
18.2.2 REVENUE ANALYSIS
18.2.3 GEOGRAPHIC PRESENCE
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPEMENTS
18.3 CRYOPAK
18.3.1 COMPANY OVERVIEW
18.3.2 REVENUE ANALYSIS
18.3.3 GEOGRAPHIC PRESENCE
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPEMENTS
18.4 GENTHERM
18.4.1 COMPANY OVERVIEW
18.4.2 REVENUE ANALYSIS
18.4.3 GEOGRAPHIC PRESENCE
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPEMENTS
18.5 COLD ICE, INC.
18.5.1 COMPANY OVERVIEW
18.5.2 REVENUE ANALYSIS
18.5.3 GEOGRAPHIC PRESENCE
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPEMENTS
18.6 NUMARK BRANDS, LLC
18.6.1 COMPANY OVERVIEW
18.6.2 REVENUE ANALYSIS
18.6.3 GEOGRAPHIC PRESENCE
18.6.4 PRODUCT PORTFOLIO
18.6.5 RECENT DEVELOPEMENTS
18.7 CERA PRODUCTS INC.
18.7.1 COMPANY OVERVIEW
18.7.2 REVENUE ANALYSIS
18.7.3 GEOGRAPHIC PRESENCE
18.7.4 PRODUCT PORTFOLIO
18.7.5 RECENT DEVELOPEMENTS
18.8 FRESENIUS MEDICAL CARE
18.8.1 COMPANY OVERVIEW
18.8.2 REVENUE ANALYSIS
18.8.3 GEOGRAPHIC PRESENCE
18.8.4 PRODUCT PORTFOLIO
18.8.5 RECENT DEVELOPEMENTS
18.9 SUN PHARMACEUTICALS
18.9.1 COMPANY OVERVIEW
18.9.2 GEOGRAPHIC PRESENCE
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPEMENTS
18.1 EAGLE PHARMACEUTICALS, INC.
18.10.1 COMPANY OVERVIEW
18.10.2 REVENUE ANALYSIS
18.10.3 GEOGRAPHIC PRESENCE
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPEMENTS
19 RELATED REPORTS
20 CONCLUSION
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
